ChromaDex Corporation
US ˙ NasdaqCM ˙ US1710774076
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

SecurityCDXC / ChromaDex Corporation
InstitutionState Street Corp
Latest Disclosed Ownership1,084,565 shares
Latest Disclosed Value $ 4,782,932
State Street Corp reports 0.59% decrease in ownership of CDXC / ChromaDex Corporation

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 1,084,565 shares of ChromaDex Corporation (US:CDXC) valued at $4,782,932 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,091,039 shares of ChromaDex Corporation. This represents a change in shares of -0.59% during the quarter. The current value of the position is $8,535,527 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,084,565 -6,474 -0.59 4,783 -31.09 0.0002
2026-02-13 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,091,039 -1,671 -0.15 6,939 -31.93 0.0002
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,092,710 72,860 7.14 10,195 -30.63 0.0004
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,019,850 92,612 9.99 14,696 129.73 0.0006
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 927,238 12,263 1.34 6,398 31.82 0.0003
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 914,975 296,947 48.05 4,854 115.21 0.0002
2024-11-14 2024-09-30 13F CHROMADEX COM NEW 171077407 618,028 62,692 11.29 2,256 48.75 0.0001
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 555,336 365,097 191.91 1,516 129.00 0.0001
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 190,239 0 0.00 662 143.38 0.0000
2024-02-14 2023-12-31 13F CHROMADEX COM NEW 171077407 190,239 0 0.00 272 -1.81 0.0000
2023-11-14 2023-09-30 13F CHROMADEX COM NEW 171077407 190,239 0 0.00 278 -7.05 0.0000
2023-08-14 2023-06-30 13F CHROMADEX COM NEW 171077407 190,239 0 0.00 299 2.41 0.0000
2023-05-15 2023-03-31 13F CHROMADEX COM NEW 171077407 190,239 13,400 7.58 291 -2.02 0.0000
2023-05-15 2022-12-31 13F/A-99 CHROMADEX COM NEW 171077407 176,839 0 0.00 297 36.24 0.0000
2023-05-15 2022-12-31 13F CHROMADEX COM NEW 171077407 176,839 0 297 0.0000
2022-11-15 2022-09-30 13F CHROMADEX COM NEW 171077407 176,839 -60,260 -25.42 218 -44.95 0.0000
2022-08-15 2022-06-30 13F CHROMADEX COM NEW 171077407 237,099 -695,427 -74.57 396 -82.74 0.0000
2022-05-16 2022-03-31 13F CHROMADEX COM NEW 171077407 932,526 36,308 4.05 2,294 -31.56 0.0001
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 896,218 10,855 1.23 3,352 -39.61 0.0002
2021-11-15 2021-09-30 13F CHROMADEX COM NEW 171077407 885,363 50,720 6.08 5,551 -32.55 0.0003
2021-08-16 2021-06-30 13F CHROMADEX COM NEW 171077407 834,643 106,207 14.58 8,230 20.96 0.0004
2021-07-09 2021-03-31 13F/A-1 CHROMADEX COM NEW 171077407 728,436 14,490 2.03 6,804 98.54 0.0004
2021-05-17 2021-03-31 13F CHROMADEX COM NEW 171077407 728,436 14,490 6,804 0.0004
2021-02-16 2020-12-31 13F CHROMADEX COM NEW 171077407 713,946 -11,644 -1.60 3,427 17.77 0.0002
2020-11-10 2020-09-30 13F CHROMADEX COM NEW 171077407 725,590 -5,392 -0.74 2,910 -13.26 0.0002
2020-08-14 2020-06-30 13F CHROMADEX COM NEW 171077407 730,982 32,560 4.66 3,355 47.34 0.0002
2020-06-19 2020-03-31 13F/A-1 CHROMADEX COM NEW 171077407 698,422 16,124 2.36 2,277 -22.58 0.0002
2020-05-11 2020-03-31 13F CHROMADEX COM NEW 171077407 698,422 16,124 2,277 199.9664
2020-02-06 2019-12-31 13F CHROMADEX COM NEW 171077407 682,298 81,755 13.61 2,941 24.46 0.0002
2019-11-14 2019-09-30 13F CHROMADEX COM NEW 171077407 600,543 17,296 2.97 2,363 -12.87 0.0002
2019-08-14 2019-06-30 13F CHROMADEX COM NEW 171077407 583,247 24,045 4.30 2,712 15.75 0.0002
2019-05-15 2019-03-31 13F CHROMADEX COM NEW 171077407 559,202 4,060 0.73 2,343 23.06 0.0002
2019-02-12 2018-12-31 13F CHROMADEX COM NEW 171077407 555,142 -10,746 -1.90 1,904 -21.52 0.0002
2018-11-09 2018-09-30 13F CHROMADEX Common equity shares 171077407 565,888 35,236 6.64 2,426 23.34 0.0002
2018-08-14 2018-06-30 13F CHROMADEX Common equity shares 171077407 530,652 506,392 2,087.35 1,967 1,828.43 0.0002
2018-05-15 2018-03-31 13F CHROMADEX Common equity shares 171077407 24,260 24,260 102 0.0000
2017-08-14 2017-06-30 13F CHROMADEX Common equity shares 171077407 0 -331,073 -100.00 0 -100.00
2017-05-15 2017-03-31 13F CHROMADEX Common equity shares 171077407 331,073 6,062 1.87 891 -17.27 0.0001
2017-02-09 2016-12-31 13F CHROMADEX Common equity shares 171077407 325,011 -3,154 -0.96 1,077 10.57 0.0001
2017-01-13 2016-09-30 13F/A-1 CHROMADEX Common equity shares 171077407 328,165 107,549 48.75 974 6.68 0.0001
2016-11-14 2016-09-30 13F CHROMADEX Common equity shares 171077407 328,165 974
2016-08-12 2016-06-30 13F CHROMADEX Common equity shares 171077407 220,616 220,616 913 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.